AtriCure Inc
NASDAQ:ATRC
AtriCure Inc
Revenue
AtriCure Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
AtriCure Inc
NASDAQ:ATRC
|
Revenue
$414.6m
|
CAGR 3-Years
25%
|
CAGR 5-Years
15%
|
CAGR 10-Years
17%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Revenue
$19.5B
|
CAGR 3-Years
4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
9%
|
|
Boston Scientific Corp
NYSE:BSX
|
Revenue
$14.7B
|
CAGR 3-Years
13%
|
CAGR 5-Years
8%
|
CAGR 10-Years
7%
|
|
Stryker Corp
NYSE:SYK
|
Revenue
$21B
|
CAGR 3-Years
13%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
Abbott Laboratories
NYSE:ABT
|
Revenue
$40.3B
|
CAGR 3-Years
3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
8%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Revenue
$7.3B
|
CAGR 3-Years
17%
|
CAGR 5-Years
14%
|
CAGR 10-Years
13%
|
AtriCure Inc
Revenue Breakdown
Breakdown by Geography
AtriCure Inc
Total Revenue:
399.2m
USD
|
United States:
333.5m
USD
|
Total International:
65.7m
USD
|
Europe:
38.5m
USD
|
Asia-Pacific:
24.5m
USD
|
Other International:
2.7m
USD
|
Breakdown by Segments
AtriCure Inc
See Also
What is AtriCure Inc's Revenue?
Revenue
414.6m
USD
Based on the financial report for Mar 31, 2024, AtriCure Inc's Revenue amounts to 414.6m USD.
What is AtriCure Inc's Revenue growth rate?
Revenue CAGR 10Y
17%
Over the last year, the Revenue growth was 19%. The average annual Revenue growth rates for AtriCure Inc have been 25% over the past three years , 15% over the past five years , and 17% over the past ten years .